Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11772 | 891 | 33.8 | 75% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
545 | 13948 | REBAMIPIDE//GASTRIC MUCOSAL BLOOD FLOW//GASTRIC MUCOSA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DIAPHRAGM DISEASE | Author keyword | 60 | 100% | 2% | 20 |
2 | SMALL INTESTINAL INJURY | Author keyword | 12 | 63% | 1% | 12 |
3 | SMALL INTESTINAL DAMAGE | Author keyword | 12 | 86% | 1% | 6 |
4 | SMALL BOWEL MUCOSAL INJURY | Author keyword | 11 | 100% | 1% | 6 |
5 | CRYPTOGENIC MULTIFOCAL ULCEROUS STENOSING ENTERITIS | Author keyword | 6 | 80% | 0% | 4 |
6 | SMALL INTESTINAL ULCER | Author keyword | 6 | 80% | 0% | 4 |
7 | INTESTINAL LESION | Author keyword | 6 | 71% | 1% | 5 |
8 | COLOPATHY | Author keyword | 5 | 47% | 1% | 8 |
9 | NSAID ENTEROPATHY | Author keyword | 5 | 63% | 1% | 5 |
10 | DRUG INDUCED DAMAGE | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIAPHRAGM DISEASE | 80 | 80% | 5% | 49 |
2 | INDUCED ENTEROPATHY | 60 | 74% | 5% | 45 |
3 | INDOMETHACIN INDUCED CHANGES | 48 | 100% | 2% | 17 |
4 | NSAID ENTEROPATHY | 31 | 82% | 2% | 18 |
5 | DIAPHRAGM LIKE STRICTURES | 26 | 100% | 1% | 11 |
6 | SMALL BOWEL INJURY | 17 | 33% | 5% | 41 |
7 | SMALL INTESTINAL INJURY | 15 | 63% | 2% | 15 |
8 | SMALL BOWEL ULCERATION | 15 | 73% | 1% | 11 |
9 | ACID ABSORPTION TEST | 12 | 86% | 1% | 6 |
10 | SMALL INTESTINAL INFLAMMATION | 11 | 69% | 1% | 9 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
NSAID-Induced Small Intestinal Damage - Roles of Various Pathogenic Factors | 2015 | 1 | 67 | 67% |
Present status and strategy of NSAIDs-induced small bowel injury | 2009 | 79 | 67 | 69% |
The impact of non-steroidal anti-inflammatory drugs on the small intestinal epithelium | 2014 | 6 | 42 | 67% |
Gastrointestinal safety of NSAIDs and over-the-counter analgesics | 2013 | 19 | 35 | 40% |
Small Intestinal Injury Caused by NSAIDs/Aspirin: Finding New from Old | 2012 | 13 | 39 | 77% |
Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy? | 2006 | 63 | 37 | 70% |
Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage | 2010 | 27 | 42 | 62% |
SIDE-EFFECTS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON THE SMALL AND LARGE-INTESTINE IN HUMANS | 1993 | 572 | 129 | 45% |
Mechanisms underlying intestinal injury induced by anti-inflammatory COX inhibitors | 2004 | 62 | 69 | 67% |
The role of mitochondria-derived reactive oxygen species in the pathogenesis of non-steroidal anti-inflammatory drug-induced small intestinal injury | 2014 | 2 | 21 | 86% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MICROBIOL PROBIOT | 2 | 27% | 0.7% | 6 |
2 | GEN INC ASSOC | 2 | 43% | 0.3% | 3 |
3 | INFLAMMATORY BOWEL DIS STUDY GRP | 1 | 18% | 0.4% | 4 |
4 | ARAGONES CIENCIAS SALUDCIBEREHD | 1 | 50% | 0.1% | 1 |
5 | CLIN DIETET GASTROENTEROL | 1 | 50% | 0.1% | 1 |
6 | COURSE MOL CELLULAR MED MED DENT SCI | 1 | 50% | 0.1% | 1 |
7 | EDIFICIO 5 | 1 | 50% | 0.1% | 1 |
8 | FED HEPATOGASTROENTEROL | 1 | 50% | 0.1% | 1 |
9 | GASTROENTEROL F02618 | 1 | 50% | 0.1% | 1 |
10 | GASTROINTESTINAL OUTCOMES UNIT | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000215499 | REBAMIPIDE//CAS 11911 87 6//QUALITY OF ULCER HEALING |
2 | 0.0000156353 | GERANYLGERANYLACETONE//TEPRENONE//GASTRIC MUCOSAL CELL |
3 | 0.0000154328 | NSAIDS//COXIBS//ROFECOXIB |
4 | 0.0000147663 | ANTIBIOTIC ASSOCIATED HEMORRHAGIC COLITIS//MANGANESE SUPEROXIDE DISMUTASE SOD//NONPSEUDOMEMBRANOUS COLITIS |
5 | 0.0000123351 | INTESTINAL PERMEABILITY//LACTULOSE//LACTULOSE MANNITOL TEST |
6 | 0.0000102195 | GASTRIC SURFACTANT//PHOSPHOLIPID COMPLEX//PHARMACOSOMES |
7 | 0.0000091062 | GASTROPROTECTION//GASTRIC ULCER//GASTROPROTECTIVE |
8 | 0.0000089642 | NABUMETONE//6 METHOXY 2 NAPHTHYLACETIC ACID//6MNA |
9 | 0.0000084624 | CAPSULE ENDOSCOPY//OBSCURE GASTROINTESTINAL BLEEDING//DOUBLE BALLOON ENTEROSCOPY |
10 | 0.0000080548 | NO ASPIRIN//NITROASPIRIN//NCX 4016 |